Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Find the best retirement strategies tailored for your 60s. Make the most of your savings and prepare for a rewarding retirement.
6,694 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Today’s trading session spotlighted PayPal as takeover rumors circulated, lifting the stock while the broader market ...
Two big drivers could push Truist stock higher in 2026: cheaper funding and faster loan growth. This article breaks d...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
RxSight's Q4 2025 earnings report could set the tone for its 2026 trajectory. This guide breaks down the key numbers,...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
NVIDIA just delivered spectacular quarterly results that surpassed expectations and reinforced its leadership in AI c...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
A new funding framework is here. The housing 21st century brings new loan options and smarter ways to build and prese...